NZYM-B.CONZYM-B.COCPH
Loading
EPS Growth Under PressureDecelerating
Percentile Rank51
Year-over-Year Change
Year-over-year earnings per share growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P51
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
20.40%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 662.07% |
| Q2 2025 | -27.50% |
| Q1 2025 | -24.53% |
| Q4 2024 | -83.64% |
| Q3 2024 | 276.74% |
| Q2 2024 | 0.00% |
| Q1 2024 | -65.87% |
| Q4 2023 | -25.44% |
| Q3 2023 | 54.34% |
| Q2 2023 | -22.61% |
| Q1 2023 | -11.29% |
| Q4 2022 | -22.95% |
| Q3 2022 | 42.76% |
| Q2 2022 | -2.68% |
| Q1 2022 | 33.04% |
| Q4 2021 | -25.58% |
| Q3 2021 | 6.36% |
| Q2 2021 | -10.16% |
| Q1 2021 | 35.19% |
| Q4 2020 | -7.91% |
| Q3 2020 | 10.96% |
| Q2 2020 | -20.83% |
| Q1 2020 | -11.66% |
| Q4 2019 | 46.19% |
| Q3 2019 | -28.53% |
| Q2 2019 | 29.46% |
| Q1 2019 | -16.32% |
| Q4 2018 | 4.35% |
| Q3 2018 | 4.15% |
| Q2 2018 | -2.93% |
| Q1 2018 | 1.87% |
| Q4 2017 | -2.90% |
| Q3 2017 | 11.74% |
| Q2 2017 | -4.26% |
| Q1 2017 | -3.73% |
| Q4 2016 | 8.06% |
| Q3 2016 | 0.81% |
| Q2 2016 | 1.23% |
| Q1 2016 | 8.00% |